Amyris (AMRS) Misses Q4 EPS by 22c

Amyris (: AMRS) reported Q4 EPS of ($0.46), $0.22 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $75.8 million versus the consensus estimate of $104.1 million.

For earnings history and earnings-related data on Amyris (AMRS) click here.

You May Also Be Interested In

• Netflix climbs following Ackman stake, up 1.8%
• Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
• Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance